Navigation Links
Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
Date:12/20/2007

those projected in any forward-looking statement. Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as uncertainties concerning the progress and ultimate outcome of the litigation involving Lonza Group AG. Additional information on these and other factors, which could affect the company's results, is included in its Securities and Exchange Commission ("SEC") filings. Finally, there may be other factors not mentioned above or included in the company's SEC filings that may cause actual results to differ materially those projected in any forward-looking statement. You should not place undue reliance on any forward-looking statements. The company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.


'/>"/>
SOURCE Northwest Biotherapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
2. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
3. Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements
4. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
5. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
6. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
7. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
8. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
9. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
10. Pressure BioSciences, Inc. Issued First Patent in Canada
11. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... , ... August 26, 2015 , ... ... announces today that a second US laboratory is to open in Manhattan, Kansas ... the continued partnership and long-term growth of research and development through collaboration with ...
(Date:8/26/2015)... FRANCISCO , Aug. 26, 2015  Platform ... that it has received a $1.5M Phase II ... (NIH) to further develop its therapeutic agent to ... clinical need in end stage renal disease (ESRD) ... the National Institute of Diabetes and Digestive and ...
(Date:8/26/2015)... Florida , August 26, 2015 ... the biggest factors fueling the optimism in biotech,s ... M&A,s, collaborations and life sciences advancements.  Active biotechnology ... are Pressure BioSciences, Inc. (OTCQB: PBIO), Sequenom, Inc. ... SRPT ), Raptor Pharmaceutical Corp. (NASDAQ: ...
(Date:8/25/2015)... ... August 25, 2015 , ... Vets Plus, Inc. ... Wis. The company has added a AS16 Sharples centrifuge to harvest products after ... bacterial or fungal fermentation process development. , The new centrifuge greatly expands ...
Breaking Biology Technology:MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7New centrifuge and fermentor expand product development capacity at Vets Plus 2
... VIENNA, Austria, March 12 f-star, an antibody,engineering ... its unique Modular Antibody Technology, announced today that ... in addition to its,headquarters in Vienna, Austria. The ... home to a number of biotech companies and ...
... March 12 iCAD, Inc. (Nasdaq:,ICAD), an industry-leading ... detection of cancer, today announced that John,DeLucia has ... Assurance and,Regulatory Affairs, reporting to iCAD President and ... years of medical device, in-vitro diagnostics,and biomedical research ...
... REDWOOD CITY, Calif., March 12 Genomic,Health, Inc. ... Scott, Ph.D.,Genomic Health,s Chairman and Chief Executive Officer, ... Healthcare Conference in Miami, FL,on March 19, 2008 ... the live and subsequently archived webcast of the,presentation, ...
Cached Biology Technology:Antibody Engineering Company f-Star Opens Second Research Site in Cambridge, UK 2iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs 2iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs 3Genomic Health to Present at Lehman Brothers Global Healthcare Conference 2
(Date:8/6/2015)... 6, 2015  Today, U.S. Congressman Mike ... ™ to learn firsthand how Silicon Valley technologies ... is a world leader in multi-factor identity management ... helping federal agencies and commercial organizations achieve new ... "The vast majority of network breaches can ...
(Date:8/5/2015)... 5, 2015 According to a ... Market by Software, Services, Vertical (BFSI, Airport, IT & Telecom, ... Global Forecast to 2020", published by MarketsandMarkets, defines and ... into various segments. The global PIAM Market is estimated ... Million by 2019, at a CAGR of 14.9 % ...
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... for the loss of millions of hours of work productivity this ... fever symptoms, including sneezing, watery eyes and runny and itchy noses, ... peak hay fever season. , While missing an hour of ... million Americans suffer from at least some symptoms related to hay ...
... normal baby. He hit all his developmental landmarks but after his ... with infection after infection. He stopped eating and was no longer ... or even looking at us anymore; he was in his own ... not potty trained, and was smearing (feces) on the walls. My ...
... at University of Copenhagen have identified a new group of ... are published in the new issue of Cell. , All ... specialised cell types that all originate from the same type ... develop into any type of cell through a carefully regulated ...
Cached Biology News:Hay fever can send work productivity down the drain 2Hay fever can send work productivity down the drain 3Army research mission focused on autism 2Army research mission focused on autism 3Army research mission focused on autism 4